Published in Clin Vaccine Immunol on August 27, 2008
Quantitation of human seroresponsiveness to Merkel cell polyomavirus. PLoS Pathog (2009) 2.08
Fulminant JC virus encephalopathy with productive infection of cortical pyramidal neurons. Ann Neurol (2009) 1.55
Distinct merkel cell polyomavirus molecular features in tumour and non tumour specimens from patients with merkel cell carcinoma. PLoS Pathog (2010) 1.40
Management of polyomavirus-associated nephropathy in renal transplant recipients. Nat Rev Nephrol (2012) 1.10
Inhibitory interactions between BK and JC virus among kidney transplant recipients. J Am Soc Nephrol (2011) 1.03
Positive correlation between Merkel cell polyomavirus viral load and capsid-specific antibody titer. Med Microbiol Immunol (2011) 1.01
Asymptomatic primary Merkel cell polyomavirus infection among adults. Emerg Infect Dis (2011) 0.99
Antibody responses to recombinant polyomavirus BK large T and VP1 proteins in young kidney transplant patients. J Clin Microbiol (2009) 0.91
The role of the immune response in merkel cell carcinoma. Cancers (Basel) (2013) 0.91
Serological evidence of an early seroconversion to Simian virus 40 in healthy children and adolescents. PLoS One (2013) 0.89
Neutralization serotyping of BK polyomavirus infection in kidney transplant recipients. PLoS Pathog (2012) 0.88
Prospective Study of Human Polyomaviruses and Risk of Cutaneous Squamous Cell Carcinoma in the United States. Cancer Epidemiol Biomarkers Prev (2016) 0.75
A delicate balance between rejection and BK polyomavirus associated nephropathy; A retrospective cohort study in renal transplant recipients. PLoS One (2017) 0.75
Pre-transplant immune factors may be associated with BK polyomavirus reactivation in kidney transplant recipients. PLoS One (2017) 0.75
BK Virus-associated Hemorrhagic Cystitis in Patients with Allogeneic Hematopoietic Cell Transplantation: Report of Three Cases. Hematol Rep (2017) 0.75
New human papovavirus (B.K.) isolated from urine after renal transplantation. Lancet (1971) 12.13
Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients. N Engl J Med (2002) 5.34
Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40. J Med Virol (2003) 3.73
Incomplete HIV type 1 antibody evolution and seroreversion in acutely infected individuals treated with early antiretroviral therapy. Clin Infect Dis (2005) 2.87
Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction. Am J Transplant (2005) 2.76
Testing for polyomavirus type BK DNA in plasma to identify renal-allograft recipients with viral nephropathy. N Engl J Med (2000) 2.63
Donor origin of BK virus in renal transplantation and role of HLA C7 in susceptibility to sustained BK viremia. Am J Transplant (2005) 2.19
Human polyomavirus infections with JC virus and BK virus in renal transplant patients. Ann Intern Med (1980) 2.07
Clinical course of polyoma virus nephropathy in 67 renal transplant patients. J Am Soc Nephrol (2002) 1.97
Loss of discrete memory B cell subsets is associated with impaired immunization responses in HIV-1 infection and may be a risk factor for invasive pneumococcal disease. J Immunol (2007) 1.96
Human polyoma virus-associated interstitial nephritis in the allograft kidney. Transplantation (1999) 1.93
Polyomavirus infection of renal allograft recipients: from latent infection to manifest disease. J Am Soc Nephrol (1999) 1.83
BK virus in solid organ transplant recipients: an emerging syndrome. Transplantation (2001) 1.75
Comparison of antibody titers determined by hemagglutination inhibition and enzyme immunoassay for JC virus and BK virus. J Clin Microbiol (2000) 1.63
Prospective monitoring of polyomavirus BK replication and impact of pre-emptive intervention in pediatric kidney recipients. Am J Transplant (2007) 1.61
Prospective study of the human polyomaviruses BK and JC and cytomegalovirus in renal transplant recipients. J Clin Pathol (1984) 1.54
Prophylactic versus preemptive oral valganciclovir for the management of cytomegalovirus infection in adult renal transplant recipients. Am J Transplant (2006) 1.52
Epstein-Barr virus-specific serology in immunologically compromised individuals. Cancer Res (1981) 1.43
Antibody response to core, envelope and nonstructural hepatitis C virus antigens: comparison of immunocompetent and immunosuppressed patients. Hepatology (1993) 1.41
Human polyoma virus in renal allograft biopsies: morphological findings and correlation with urine cytology. Hum Pathol (1999) 1.39
Disseminated BK type polyomavirus infection in an AIDS patient associated with central nervous system disease. Am J Pathol (1993) 1.37
Morphological spectrum of polyoma virus disease in renal allografts: diagnostic accuracy of urine cytology. Am J Transplant (2001) 1.28
BK polyoma virus allograft nephropathy: ultrastructural features from viral cell entry to lysis. Am J Transplant (2003) 1.28
Prospective monitoring of BK virus load after discontinuing sirolimus treatment in a renal transplant patient with BK virus nephropathy. J Infect Dis (2001) 1.27
Primary cytomegalovirus and opportunistic infections. Incidence in renal transplant recipients. JAMA (1978) 1.24
Tubulo-interstitial nephritis associated with polyomavirus (BK type) infection. N Engl J Med (1983) 1.17
Nephropathy due to polyomavirus type BK. N Engl J Med (2000) 1.16
Immunoglobulin G, A, and M responses to BK virus in renal transplantation. Clin Vaccine Immunol (2006) 1.12
Polyomavirus BK infection in pediatric kidney-allograft recipients: a single-center analysis of incidence, risk factors, and novel therapeutic approaches. Transplantation (2003) 1.06
A longitudinal molecular surveillance study of human polyomavirus viremia in heart, kidney, liver, and pancreas transplant patients. J Infect Dis (2005) 1.05
Incidence, prevalence, and clinical course of hepatitis C following liver transplantation. Gastroenterology (1992) 1.04
Serological investigation of BK papovavirus infection in pregnant women and their offspring. Infect Immun (1980) 1.04
Full or partial seroreversion in patients infected by hepatitis C virus. J Infect Dis (1997) 1.03
Polyomavirus nephropathy in pediatric kidney transplant recipients. Am J Transplant (2004) 1.00
BK virus-specific antibodies and BKV DNA in renal transplant recipients with BKV nephritis. Am J Transplant (2005) 0.96
BK antibody and virus-specific IgM responses in renal transplant recipients, patients with malignant disease, and healthy people. Br Med J (1977) 0.96
A prospective study of BK-virus-associated haemorrhagic cystitis in paediatric patients undergoing allogeneic haematopoietic stem cell transplantation. Bone Marrow Transplant (2007) 0.95
Relationship of pretransplantation polyoma BK virus serologic findings and BK viral reactivation after hematopoietic stem cell transplantation. Clin Infect Dis (2007) 0.92
The presence of hepatitis C virus (HCV) antibody in human immunodeficiency virus-positive hemophilic men undergoing HCV "seroreversion". Blood (1993) 0.91
BK virus infection in AIDS. Am J Surg Pathol (2000) 0.90
Incidence and outcome of primary Epstein-Barr virus infection and lymphoproliferative disease in pediatric heart transplant recipients. J Heart Lung Transplant (1998) 0.86
Adolescents are more likely to develop posttransplant lymphoproliferative disorder after primary Epstein-Barr virus infection than younger renal transplant recipients. Transplantation (2007) 0.86
Seroreversion of HIV antibodies in patients with prolonged suppression of viraemia under HAART. AIDS (2006) 0.85
Human polyoma virus type BK infection and T antibody response in renal transplant recipients. Zentralbl Bakteriol Mikrobiol Hyg A (1987) 0.84
Characteristics of Epstein-Barr virus primary infection in pediatric liver transplant recipients. J Hepatol (2000) 0.79
Prophylaxis of primary cytomegalovirus disease in renal transplant recipients. A trial of ganciclovir vs immunoglobulin. Arch Surg (1994) 0.79
The importance of pre-treatment of human sera for the titration of hemagglutination-inhibiting antibodies towards BK virus. Ann Sclavo (1980) 0.79
Epstein-Barr virus infection in sixty pediatric liver graft recipients: diagnosis of primary infection and virologic follow-up. Pediatr Infect Dis J (1999) 0.78
Kidney transplantation under FK 506. JAMA (1990) 7.45
Genotypic assessment of isoniazid and rifampin resistance in Mycobacterium tuberculosis: a blind study at reference laboratory level. J Clin Microbiol (1997) 5.09
Liver, kidney, and thoracic organ transplantation under FK 506. Ann Surg (1990) 5.01
Nucleic acid reactivity and conformation. II. Reaction of cytosine and uracil with sodium bisulfite. J Biol Chem (1973) 4.44
Isolation rates and toxigenic potential of Clostridium difficile isolates from various patient populations. Gastroenterology (1981) 4.04
X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling. Nat Genet (2001) 3.86
The morphogen Sonic hedgehog is an indirect angiogenic agent upregulating two families of angiogenic growth factors. Nat Med (2001) 3.85
CTX-M-5, a novel cefotaxime-hydrolyzing beta-lactamase from an outbreak of Salmonella typhimurium in Latvia. Antimicrob Agents Chemother (1998) 3.74
The impact of conversion from prograf to generic tacrolimus in liver and kidney transplant recipients with stable graft function. Am J Transplant (2011) 3.42
Toxicity evaluation of replication-competent herpes simplex virus (ICP 34.5 null mutant 1716) in patients with recurrent malignant glioma. Gene Ther (2000) 2.94
Deamination of cytosine derivatives by bisulfite. Mechanism of the reaction. J Am Chem Soc (1974) 2.92
Long-term survival after liver transplantation in 4,000 consecutive patients at a single center. Ann Surg (2000) 2.91
Medical education and health for all. Aust J Public Health (1995) 2.65
Bias in reporting of end points of efficacy and toxicity in randomized, clinical trials for women with breast cancer. Ann Oncol (2013) 2.51
FK506 "rescue" for resistant rejection of renal allografts under primary cyclosporine immunosuppression. Transplantation (1994) 2.50
Living donor renal transplantation using alemtuzumab induction and tacrolimus monotherapy. Am J Transplant (2006) 2.48
The deamination of cytidine and cytosine by acidic buffer solutions. Mutagenic implications. Biochemistry (1966) 2.30
Endostatin inhibits VEGF-induced endothelial cell migration and tumor growth independently of zinc binding. EMBO J (1999) 2.28
On the reaction of guanine with glyoxal, pyruvaldehyde, and kethoxal, and the structure of the acylguanines. A new synthesis of N2-alkylguanines. Biochemistry (1969) 2.25
An assessment of the adequacy of self-care by adult asthmatics. J Community Health (1980) 2.25
Overview: deinstitutionalization of psychiatric patients, a critical review of outcome studies. Am J Psychiatry (1981) 2.24
Should HLA mismatch acceptability for sensitized transplant candidates be determined at the high-resolution rather than the antigen level? Am J Transplant (2015) 2.24
A critical appraisal of methods to grade transplant glomerulitis in renal allograft biopsies. Am J Transplant (2010) 2.14
Efficient and stable adeno-associated virus-mediated transduction in the skeletal muscle of adult immunocompetent mice. Hum Gene Ther (1997) 2.09
Epidemiologic and microbiologic correlates of Chlamydia trachomatis infection in sexual partnerships. JAMA (1996) 2.07
Diagnosis of Chlamydia trachomatis eye infection in Tanzania by polymerase chain reaction/enzyme immunoassay. Lancet (1991) 2.06
Characteristic ribonucleolytic activity of human angiogenin. Biochemistry (1986) 2.06
Serum antibody response to toxins A and B of Clostridium difficile. J Infect Dis (1983) 2.03
Quantifying the risk of incompatible kidney transplantation: a multicenter study. Am J Transplant (2014) 2.00
Human polyoma virus-associated interstitial nephritis in the allograft kidney. Transplantation (1999) 1.93
The point system for organ distribution. Transplant Proc (1989) 1.88
Correction of lysosomal storage in the liver and spleen of MPS VII mice by implantation of genetically modified skin fibroblasts. Nat Genet (1993) 1.87
Experience with liver and kidney allografts from non-heart-beating donors. Transplantation (1995) 1.83
Molecular recognition of human angiogenin by placental ribonuclease inhibitor--an X-ray crystallographic study at 2.0 A resolution. EMBO J (1997) 1.77
Nicotine effects on adults with attention-deficit/hyperactivity disorder. Psychopharmacology (Berl) (1996) 1.75
Specific acylation of the guanine residues of ribonucleic acid. J Biol Chem (1970) 1.74
Transcription of the HS2 enhancer toward a cis-linked gene is independent of the orientation, position, and distance of the enhancer relative to the gene. Mol Cell Biol (1997) 1.62
Cryoablation of unresectable malignant liver tumors. Am J Surg (1996) 1.62
Transdermal nicotine effects on attention. Psychopharmacology (Berl) (1998) 1.61
Sporadic legionellosis in the United States: the first thousand cases. Ann Intern Med (1981) 1.60
Viral hepatitis associated with day-care centers. JAMA (1979) 1.60
Donor-transmitted malignancies in organ transplantation: assessment of clinical risk. Am J Transplant (2011) 1.59
Inhibition of HIV infection by a novel CD4 domain 2-specific monoclonal antibody. Dissecting the basis for its inhibitory effect on HIV-induced cell fusion. J Immunol (1992) 1.58
Nicotine and attention in adult attention deficit hyperactivity disorder (ADHD). Psychopharmacol Bull (1996) 1.58
The 'two, one, zero' decision: what to do with suboptimal deceased donor kidneys. Am J Transplant (2010) 1.58
Tight-binding inhibition of angiogenin and ribonuclease A by placental ribonuclease inhibitor. Biochemistry (1989) 1.57
Sites of nonenzymatic glycosylation of human hemoglobin A. J Biol Chem (1980) 1.56
New onset of diabetes in FK 506 vs cyclosporine-treated kidney transplant recipients. Transplant Proc (1991) 1.56
Regular articles: conditional disruption of hedgehog signaling pathway defines its critical role in hair development and regeneration. J Invest Dermatol (2000) 1.56
Comparison of FK-506 and cyclosporine regimens in pediatric renal transplantation. Pediatr Nephrol (1994) 1.55
Human placental ribonuclease inhibitor abolishes both angiogenic and ribonucleolytic activities of angiogenin. Proc Natl Acad Sci U S A (1987) 1.55
Multiple enzymatic activities associated with recombinant NS3 protein of hepatitis C virus. J Virol (1998) 1.54
Acidic hydrolysis of deoxycytidine and deoxyuridine derivatives. The general mechanism of deoxyribonucleoside hydrolysis. Biochemistry (1972) 1.54
Nosocomial outbreak of tuberculosis in a renal transplant unit: application of a new technique for restriction fragment length polymorphism analysis of Mycobacterium tuberculosis isolates. J Infect Dis (1993) 1.53
Posterior reversible encephalopathy syndrome after solid organ transplantation. AJNR Am J Neuroradiol (2008) 1.53
"Plasma cell hepatitis" in liver allografts: identification and characterization of an IgG4-rich cohort. Am J Transplant (2013) 1.52
Gene typing of Chlamydia trachomatis by polymerase chain reaction and restriction endonuclease digestion. Sex Transm Dis (1993) 1.52
Bisulfite-catalyzed transamination of cytosine and cytidine. Biochem Biophys Res Commun (1970) 1.52
Isolation and identification of cross-links from formaldehyde-treated nucleic acids. Biochemistry (1980) 1.52
Ethical considerations for participation of nondirected living donors in kidney exchange programs. Am J Transplant (2010) 1.51
The reaction of guanine derivatives with 1,2-dicarbonyl compounds. Biochemistry (1966) 1.50
Uncatalyzed hydrolysis of deoxyuridine, thymidine, and 5-bromodeoxyuridine. Biochemistry (1969) 1.49
Pancreas transplantation with enteric drainage under tacrolimus induction therapy. Transplant Proc (1997) 1.48
The mutagenic specificity of sodium bisulfite. Biochem Biophys Res Commun (1970) 1.48
Linear single-dose pharmacokinetics of ganciclovir in newborns with congenital cytomegalovirus infections. NIAID Collaborative Antiviral Study Group. Clin Pharmacol Ther (1993) 1.47
Percutaneous cementoplasty of acetabular bony metastasis. Surgeon (2003) 1.45
Antibody-mediated rejection of human orthotopic liver allografts. A study of liver transplantation across ABO blood group barriers. Am J Pathol (1988) 1.45
Structure of adeno-associated virus vector DNA following transduction of the skeletal muscle. J Virol (1999) 1.44
Crystal structure of the superantigen enterotoxin C2 from Staphylococcus aureus reveals a zinc-binding site. Structure (1995) 1.42
Adverse effects associated with the use of FK 506. Transplant Proc (1991) 1.41
Ciprofloxacin does not block the antiproliferative effect of tacrolimus. Transplantation (1997) 1.39
Mechanism of obstruction of the infradiaphragmatic portion of the inferior vena cava in the presence of increased intra-abdominal pressure. Invest Radiol (1966) 1.39
Sporadic community-acquired Legionnaires' disease in the United States. A case-control study. Ann Intern Med (1979) 1.37
FK 506 conversion of renal allografts failing cyclosporine immunosuppression. Transplant Proc (1991) 1.37
Diffuse skeletal abnormalities in Forestier disease. Arch Intern Med (1976) 1.37
Embryogenesis of the human occipital bone. AJR Am J Roentgenol (1976) 1.36
Contribution of naïve and memory T-cell populations to the human alloimmune response. Am J Transplant (2009) 1.34
The histopathological changes associated with allograft rejection and drug toxicity in renal transplant recipients maintained on FK506. Clinical significance and comparison with cyclosporine. Am J Surg Pathol (1993) 1.32
Two-year follow-up of the patients included in the WHO International Pilot Study of Schizophrenia. Psychol Med (1977) 1.32
Indomethacin-induced prostaglandin inhibition with hyperkalemia. A reversible cause of hyporeninemic hypoaldosteronism. Ann Intern Med (1979) 1.30
Structural heterogeneity of human hemoglobin A due to nonenzymatic glycosylation. J Biol Chem (1979) 1.30
Effects of chronic nicotine and methylphenidate in adults with attention deficit/hyperactivity disorder. Exp Clin Psychopharmacol (2001) 1.30
Crystal structure of human angiogenin reveals the structural basis for its functional divergence from ribonuclease. Proc Natl Acad Sci U S A (1994) 1.30
Dual site model for the organogenic activity of angiogenin. Proc Natl Acad Sci U S A (1991) 1.29
BK virus infection in a kidney allograft diagnosed by needle biopsy. Am J Kidney Dis (1995) 1.28
Serologic response to human papillomavirus type 16 (HPV-16) virus-like particles in HPV-16 DNA-positive invasive cervical cancer and cervical intraepithelial neoplasia grade III patients and controls from Colombia and Spain. J Infect Dis (1995) 1.27
Sampling methodologies and dosage assessment techniques for submicrometre and ultrafine virus aerosol particles. J Appl Microbiol (2005) 1.26
The Danish twin register. Acta Genet Med Gemellol (Roma) (1968) 1.25
Leukotriene A4 hydrolase: determination of the three zinc-binding ligands by site-directed mutagenesis and zinc analysis. Proc Natl Acad Sci U S A (1991) 1.25
Pseudomonas folliculitis. Development after the home use of personal whirlpool spa. Cutis (1980) 1.24
Ovarian carcinomatosis presenting with hyperamylasemia and pleural effusion. Am J Gastroenterol (1981) 1.24
Characteristic immune abnormalities in hemophagocytic lymphohistiocytosis. J Pediatr Hematol Oncol (1996) 1.24
Simultaneous administration of adjuvant donor bone marrow in pancreas transplant recipients. Ann Surg (1999) 1.24
Isolation and characterization of a human colon carcinoma-secreted enzyme with pancreatic ribonuclease-like activity. Biochemistry (1986) 1.24
Augmentation of chimerism in whole organ recipients by simultaneous infusion of donor bone marrow cells. Transplant Proc (1995) 1.24
The effect of legislative requirements on the use of breast-conserving surgery. N Engl J Med (1996) 1.24
Regulatory dendritic cell infusion prolongs kidney allograft survival in nonhuman primates. Am J Transplant (2013) 1.22
Recipient tissue factor expression is associated with consumptive coagulopathy in pig-to-primate kidney xenotransplantation. Am J Transplant (2010) 1.21
Fine-needle aspiration biopsy in pancreatic transplantation. Transplant Proc (1995) 1.21
The reaction of ribonucleosides with nitrous acid. Side products and kinetics. Biochemistry (1968) 1.20